Yearly Archives: 2007

Abdominal fat, the spare tire that many of us carry, has long been implicated as a primary suspect in causing the metabolic syndrome, a cluster of conditions that includes the most dangerous heart attack risk factors: prediabetes, diabetes, high blood pressure, and changes in cholesterol.

Most oral medications prescribed for type 2 diabetes are similarly effective for reducing blood glucose, but the drug metformin is less likely to cause weight gain and may be more likely than other treatments to decrease so-called bad cholesterol. The new study directly compared 10 oral medications.

An obese person is more likely than a lean person to develop multiple myeloma, according to researchers. Their findings indicate that Body Mass Index provides an indicator for one's risk of developing multiple myeloma.

Scientists have shown for the first time that a protein involved in the transfer of fat in the blood may also influence how fat cells store fat.

Individuals with diabetes appear to spend more days in the intensive care unit, use more ventilator support and have more complications during hospitalization for trauma than non-diabetics, according to a July 2007 report.

A study from Children's Hospital Boston finds that reducing insulin levels in the brain boosts longevity. Though it was done in genetically engineered mice, old-fashioned exercise and good diets also keep brain insulin levels low in humans.

Orange juice, despite its high caloric load of sugars, appears to be a healthy food for diabetics due to its mother lode of flavonoids, a study by endocrinologists at the University at Buffalo has shown.

Little evidence supports using rosiglitazone (Avandia) to improve the quality or length of life among adults with diabetes, according to a systematic review of data by German researchers.

New studies are needed to assess the trade-offs between potential benefits and potential harms when rosiglitazone is used by people with type 2 diabetes.

There is currently no evidence available of a superiority of rapid-acting insulin analogues over human insulin in the treatment of adult patients with diabetes mellitus type 1.

There are no high quality data to assess how well dietary treatments for type 2 diabetes work in people who have just been told they have the disease, but there is evidence that taking on exercise seems to be one way of improving blood sugar levels.

Put aside the white bread and pick up an apple. A diet of foods less likely to spike blood sugar levels helps dieters lose more weight, according to a new systematic review from Australia.

Pediatrics researchers have identified a gene variant that raises a child's risk for type 1 diabetes, formerly called juvenile diabetes.

Using innovative high-density DNA microchip technology, which can test 550,000 genes in a single analysis, researchers have detected a new gene involved in type 1 diabetes.

A review of previous studies indicates that use of a class of medications known as "incretin-based therapy", which act via certain pathways that affect glucose metabolism may provide modest effectiveness and favorable weight change outcomes for the treatment of type 2 diabetes and may represent an alternative to other hypoglycemic therapies.

The U.S. obesity prevalence increased from 13 percent to 32 percent between the 1960s and 2004.